Nickson Philip
SEC insider (Form 3/4/5 filer). CIK 0001911369. Chief Business & Legal Officer at Monte Rosa Therapeutics, Inc. (GLUE). 4 reported Form 4/5 transactions since Sep 2024; latest on Apr 9, 2026. Located in BOSTON, MA.
Companies Nickson Philip has filed insider reports for
- Monte Rosa Therapeutics, Inc. (GLUE): Officer, Chief Business & Legal Officer
Nickson Philip
CIK: 0001911369
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GLUE
Monte Rosa Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Apr 9, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect5.8K shares at avg. $17.69$103K - Jan 5, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect3.2K shares at avg. $15.17$48K - Jan 2, 2026GLUE
Monte Rosa Therapeutics, Inc.
AwardDirect28K shares- - Jan 2, 2025GLUE
Monte Rosa Therapeutics, Inc.
AwardDirect36K shares-
1-4 of 4 transactions